Retinoic acid resistance at late stages of human papillomavirus type 16- mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor- β

Virology

Volumn 270, Issue 2, 2000, Pages 397-407

  Borger, Darrell R ^a   Mi, Yi De ^a   Geslani, Gemma ^b   Zyzak, Li Li ^a   Batova, Ayse ^b   Engin, Timur S W ^a   Pirisi, Lucia ^a   Creek, Kim E ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MESSENGER RNA; RECEPTOR SUBTYPE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARCINOMA; CELL GROWTH; CELL PROTECTION; CHEMOSENSITIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0034630912     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0282     Document Type: Article

References (47)

1. Attisano L., Wrana J. L., Lopez-Casillas F., Massague J. TGF-β receptors and actions. Biochim. Biophys. Acta. 1222:1994;71-80.
2. Bartsch D., Boye B., Baust C., zur Hausen H., Schwarz E. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J. 11:1992;2283-2291.
3. Batova A., Danielpour D., Pirisi L., Creek K. E. Retinoic acid induces secretion of latent transforming growth factor β1 and β2 in normal and human papillomavirus type 16-immortalized human keratinocytes. Cell Growth Differ. 3:1992;763-772.
4. Braun L., Durst M., Mikumo R., Gruppuso P. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor β1. Cancer Res. 50:1990;7324-7332.
5. Coffey R. J., Sipes N. J., Bascom C. C., Graves-Deal R., Pennington C. Y., Weissman B. E., Moses H. L. Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res. 48:1988;1596-1602.
6. Creek K. E., Jenkins J. R., Khan M. A., Batova A., Hodam J. R., Tolleson W. H., Pirisi L. Retinoic acid suppresses human papillomavirus type 16 (HPV16)-mediated transformation of human keratinocytes and inhibits the expression of the HPV16 oncogenes. Jacobs M. M. Diet and Cancer: Markers, Prevention, and Treatment. 1994;19-35 Plenum, New York.
7. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
8. DiPaolo J. A., Woodworth C. D., Popescu N., Doniger J. Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus type 16 DNA and viral Harvey ras. Oncogene. 4:1989;395-399.
9. DiPaolo J. A., Woodworth C. D., Popescu N. C., Koval D. L., Lopez J. V., Doniger J. HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytes. Virology. 177:1990;777-779.
10. Durst M., Dzarlieva-Petrusevska R. T., Boukamp P., Fusenig N. E., Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene. 1:1987;251-256.
11. Fisher G. J., Talwar H. S., Xiao J.-H., Datta S. C., Reddy A. P., Gaub M.-P., Rochette-Egly C., Chambon P., Voorhees J. J. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J. Biol. Chem. 269:1994;20629-20635.
12. Geisen C., Denk C., Gremm B., Baust C., Karger A., Bollag W., Schwarz E. High-level expression of the retinoic acid receptor β gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor α and is abnormally down-regulated in cervical carcinoma cells. Cancer Res. 57:1997;1460-1467.
13. Geradts J., Chen J.-Y., Russell E. K., Yankaskas J. R., Nieves L., Minna J. D. Human lung cancer cell lines exhibit resistance to retinoic acid treatment. Cell Growth Differ. 4:1993;799-809.
14. Glick A. B., Flanders K. C., Danielpour D., Yuspa S. H., Sporn M. B. Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul. 1:1989;87-97.
15. Graham V., Surwit E. S., Weiner S., Meyskens F. L. Phase II trial of β-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. West. J. Med. 145:1986;192-195.
16. Hietanen S., Auvinen E., Syrjanen K., Syrjanen S. Anti-proliferative effect of retinoids and interferon-α-2a on vaginal cell lines derived from squamous intra-epithelial lesions. Int. J. Cancer. 78:1998;338-345.
17. Hong W. K., Lippmann S. M., Hittelman W. N., Lotan R. Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinic. Clin. Cancer Res. 1:1995;677-686.
18. Kaur P., McDougall J. K. Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J. Virol. 62:1988;1917-1924.
19. Khan M. A., Jenkins G. R., Tolleson W. H., Creek K. E., Pirisi L. Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes. Cancer Res. 53:1993;905-909.
20. Kim Y.-H., Dohi D. F., Han G. R., Zou C.-P., Oridate N., Walsh G. L., Nesbitt J. C., Xu X.-C., Hong W. K., Lotan R., Kurie J. M. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res. 55:1995;5603-5610.
21. Lippman S. M., Benner S. E., Hong W. K. Cancer chemoprevention. J. Clin. Oncol. 12:1994;851-873.
22. Lotan R., Xu X.-C., Lippman S. M., Ro J. Y., Lee J. S., Lee J. J., Hong W. K. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N. Engl. J. Med. 332:1995;1405-1410.
23. Mader S., Leroy P., Chen J.-Y., Chambon P. Multiple parameters control the selectivity of nuclear receptors for their response elements: Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. J. Biol. Chem. 268:1993;591-600.
24. Madisen L., Webb N. R., Rose T. M., Marquardt H., Ikeda T., Twardzik D., Seyedin S., Purchio A. F. Transforming growth factor-β2: cDNA cloning and sequence analysis. DNA. 7:1988;1-8.
25. Mangelsdorf D., Umesono K., Evans R. The retinoid receptors. Sporn M., Roberts A., Goodman D. The Retinoids: Biology, Chemistry, and Medicine. 1994;319-349 Raven Press, New York.
26. Meyskens F. L., Graham V., Chvapil M., Dorr R. T., Alberts D. S., Surwit E. A. A phase I trial of β-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild or moderate intraepithelial cervical neoplasia. J. Natl. Cancer Inst. 71:1983;921-925.
27. Meyskens F. L., Surwit E., Moon T. E., Childers J. M., Davis J. R., Dorr R. T., Johnson C. S., Alberts D. S. Enhancement of regression of cervical intraepithelial neoplasia (moderate dysplasia) with topically applied all-trans-retinoic acid: A randomized trial. J. Natl. Cancer Inst. 86:1994;539-543.
28. Meyskens F. L., Manetta A. Prevention of cervical intraepithelial neoplasia and cervical cancer. Am. J. Clin. Nutr. 62:1995;1417-1419.
29. Mi Y., Borger D. R., Fernandes P. R., Pirisi L., Creek K. E. Loss of transforming growth factor-β (TGF-β) receptor type I mediates TGF-β resistance in human papillomavirus type 16 transformed human keratinocytes at late stages of in vitro progression. Virology. 270:2000;408-416.
30. Miyazono K., Dijke P. T., Ichijo H., Heldin C.-H. Receptors for transforming growth factor-β Adv. Immun. 55:1994;181-220.
31. Monzon R. I., Fillmore C., Hudson L. G. Functional consequences of reduced retinoic acid receptor γ expression in a human squamous cell carcinoma line. Mol. Pharmacol. 51:1997;377-382.
32. Pfister F. The role of human papillomavirus in anogenital cancer. Obstetr. Gynecol. Clin. N. Am. 23:1996;579-595.
33. Pietenpol J., Stein R. W., Moran E., Yaciuk P., Schlegel R., Lyons R. M., Pittelkow M. R., Munger K., Howley P. M., Moses H. L. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell. 61:1990;777-785.
34. Pirisi L., Yasumoto S., Feller M., Doniger J., DiPaolo J. A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 61:1987;1061-1066.
35. Pirisi L., Creek K. E., Doniger J., DiPaolo J. A. Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis. 9:1988;1573-1579.
36. Pirisi L., Batova A., Jenkins G. R., Hodam J. R., Creek K. E. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids. Cancer Res. 52:1992;187-193.
37. Rochette-Egly C., Lutz Y., Saunders M., Scheuer I., Gaub M.-P., Chambon P. Retinoic acid receptor γ: Specific immunodetection and phosphorylation. J. Cell Biol. 115:1991;535-545.
38. Sarma D., Yang X., Jin G., Shindoh M., Pater M. M., Pater A. Resistance to retinoic acid and altered cytokeratin expression of human papillomavirus type 16-immortalized endocervical cells after tumorigenesis. Int. J. Cancer. 65:1996;345-350.
39. Shipley G. D., Pittelkow M. R., Wille J. J., Scott R. E., Moses H. L. Reversible inhibition of normal human prokeratinocyte proliferation by type β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46:1986;2068-2071.
40. Widschwendter M., Berger J., Daxenbichler G., Muller-Holzner E., Widschwendter A., Mayr A., Marth C., Zeimet A. G. Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res. 57:1997;4158-4161.
41. Woodworth C. D., Bowden P. E., Doniger J., Pirisi L., Barnes W., Lancaster W. D., DiPaolo J. A. Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA. Cancer Res. 48:1988;4620-4628.
42. Woodworth C. D., Doniger J., DiPaolo J. A. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J. Virol. 63:1989;159-164.
43. Woodworth C. D., Notario V., DiPaolo J. A. Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells. J. Virol. 64:1990;4767-4775.
44. Wrana J. L., Attisano L., Weiser R., Venturs F., Massague J. Mechanism of activation of the TGF-β receptor. Nature. 370:1994;341-347.
45. Xu X.-C., Sozzi G., Lee J. S., Lee J. J., Pastorino U., Pilotti S., Kurie J. M., Hong W. K., Lotan R. Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: Implications for lung cancer development. J. Natl. Cancer Inst. 89:1997a;624-629.
46. Xu X. C., Sneige N., Liu X., Nandagiri R., Lee J. J., Lukmanji F., Hortobagyi G., Lippman S. M., Dhingra K., Lotan R. Progressive decrease in nuclear retinoic acid receptor β messenger RNA level during breast carcinogenesis. Cancer Res. 57:1997b;4992-4996.
47. Zyzak L. L., MacDonald L. M., Batova A., Forand R., Creek K. E., Pirisi L. Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16-immortalized human keratinocytes. Cell Growth Differ. 5:1994;537-547.